% !TeX root = ./main.tex

\documentclass[fleqn,10pt]{wlscirep}
\usepackage[utf8]{inputenc}
\usepackage[T1]{fontenc}
\title{SPIDIA blood stabilization study: Extreme upregulation of gene expression is mediated by improper blood incubation in EDTA tubes}

\input{affiliations.tex}

%\keywords{Preanalytical phase, EDTA tubes, PAXgene tubes, mRNA, gene expression, quality of samples, degradation}

\input{abstract.tex}

\begin{document}

\flushbottom
\maketitle
% * <john.hammersley@gmail.com> 2015-02-09T12:07:31.197Z:
%
%  Click the title above to edit the author information and abstract
%
\thispagestyle{empty}

\noindent 

\section*{Introduction}
\input{introduction.tex}

\section*{Results}
%\input{results.tex

\section*{Discussion}
%\input{disscussion.tex}

\section*{Methods}
%\input{methods.tex}

\bibliography{sample}

\noindent 
LaTeX formats citations and references automatically using the bibliography records in your .bib file, which you can edit via the project menu. Use the cite command for an inline citation, e.g.  \cite{Hao:gidmaps:2014}.

For data citations of datasets uploaded to e.g. \emph{figshare}, please use the \verb|howpublished| option in the bib entry to specify the platform and the link, as in the \verb|Hao:gidmaps:2014| example in the sample bibliography file.

\section*{Acknowledgements}

We would like to acknowledge former members of Institute of Experimental Medicine of the Czech Academy of Sciences, Department of Molecular Genetics, Prague, 142 20, Czech Republic: Dr. Pavel Vodička and Dr. Jana Slyšková for providing EDTA samples for confirmatory testing. Experiments and descriptions of these samples were previously published in Slyšková et al., 2015.
% Doplnit referenci k článku a svolení k pokusům
This work was supported by EU grant FP7-HEALTH-2007-B-222916: SPIDIA (Standardisation and improvement of generic pre-analytical tools and procedures for in vitro diagnostics) and by the Grant Agency of the Charles University, Prague, Czech Republic (PRIMUS/20/MED/008). 

\section*{Author contributions statement}

All authors participated in the design of the work, interpretation of data, and revision of the manuscript. R.W., M.K., U.O.: collection of samples, isolation of RNA, and quality control of samples. R.S., J.B., D.S., M.K.: design and validation of primers. H.Z., E.R.: precision experiments using designed primers. V.K.: acquisition of qPCR data, analysis, interpretation of data, and drafting of the manuscript. L.Z.: acquisition of qPCR data. P.V., S.P., C.M.C., V.N.: statistical analysis.

\section*{Additional information}

S1. Information on primers.
S2. EDTA: collected samples and their characteristics.
S3. EDTA: prevalidation data.
S4. EDTA: validation data.
S5. EDTA: data for confirmatory experiment.
S6. EDTA: plots and statistics from prevalidation and validation results.
S7. PAXgene: collected samples and their characteristics.
S8. PAXgene: prevalidation data.
S9. PAXgene: validation data.
S10. PAXgene: plots and statistics from prevalidation and validation results.

To include, in this order: \textbf{Accession codes} (where applicable); \textbf{Competing interests} (mandatory statement). 

The corresponding author is responsible for submitting a \href{http://www.nature.com/srep/policies/index.html#competing}{competing interests statement} on behalf of all authors of the paper. This statement must be included in the submitted article file.

\begin{figure}[ht]
\centering
\includegraphics[width=\linewidth]{figure1}
\caption{Study design.}
\label{fig:figure1}
\end{figure}
% Figure1 ještě prověřit, jestli je vše updatované, pro EDTA beru pouze S.Předělat všechny grafy na medián.

\begin{figure}[ht]
    \centering
    \includegraphics[width=\linewidth]{figure2}
    \caption{EDTA pre-validation: Time-dependent gene expression changes of EDTA upregulation markers.}
    \label{fig:figure2}
    \end{figure}
% Figure2, změnit popisek na ose x a vynechat všechny downregulované M. Zrušit nadpis grafu a do x ještě přidat EDTA tubes. Vymazat všechna S z názvu.

\begin{figure}[ht]
    \centering
    \includegraphics[width=\linewidth]{figure3}
    \caption{Time-depended degradation of both RNA and gene expression levels.}
    \label{fig:figure3}
    \end{figure}
% Figure3. Je to medián.

\begin{figure}[ht]
    \centering
    \includegraphics[width=\linewidth]{figure4}
    \caption{EDTA validation.SCI.}
    \label{fig:figure4}
    \end{figure}
% Figure4  Tady asi celkově předělat graf a barvy. Sjednotit popisky na x ose.

\begin{figure}[ht]
    \centering
    \includegraphics[width=\linewidth]{figure5}
    \caption{3D PCA. Red dots represent control samples at 24 hours, black dots represent control samples at 6 hours, and green dots represent control samples at 0 hours. Gray dots are tested samples. Data are autoscaled.}
    \label{fig:figure5}
    \end{figure}
% Figure5 Možná udělat bílé pozdadí a popsat, co jsou ty čáry mezi dots.

\begin{figure}[ht]
    \centering
    \includegraphics[width=\linewidth]{figure6}
    \caption{Normalized PAXgene candidate markers for degradation of gene expression measured over time. A) Degradation at RT. B) Degradation at 30°C.}
    \label{fig:figure6}
    \end{figure}
% Figure6 tohle by mělo být v pořádku, ale nějak vymyslet ten popisek, aby byly jasné ty procenta, je to jen screenshot png, ještě předělat popisky a dole nemůže být jen T24, ale delta T24  


\begin{figure}[ht]
    \centering
    \includegraphics[width=\linewidth]{figure7}
    \caption{RNA Integrity Number (RIN) measured in whole blood samples (N = 7) incubated in PAXgene RNA tubes at room temperature (RT) and at 30°C.}
    \label{fig:figure7}
    \end{figure}
% Figure7 V pravém obrázku je dole PAX30, sjednotit obě osy v obou obrázcích, neopakovat vysvětlení zkratky v popisku.

Figures and tables can be referenced in LaTeX using the ref command, e.g. Figure \ref{fig:stream} and Table \ref{tab:example}.

\end{document}